Use of chloramphenicol as topical eye medication: time to cry halt?
Authors:
- Marie DoonaMDMarie Doona
- J Bernard WalshJWJ Bernard Walsh
Abstract
Since 1950, when Rich et al highlighted the relation between oral chloramphenicol and bone marrow aplasia,2 doctors have been well aware of this side effect. The first death resulting from bone marrow aplasia induced by chloramphenicol eye drops was described by Rosenthal and Blackman in 1955.3 Numerous subsequent …Keywords
This publication has 10 references indexed in Scilit:
- Blood Dyscrasias and Topical Ophthalmic ChloramphenicolAmerican Journal of Ophthalmology, 1993
- Adult pure red cell aplasia following topical ocular chloramphenicol.British Journal of Ophthalmology, 1990
- Survey of patients taking topical medication at their first presentation to eye casualty.BMJ, 1990
- Drug-Induced Aplastic Anemia: Pathogenesis and Clinical AspectsJournal of Pediatric Hematology/Oncology, 1990
- OPHTHALMIC USE OF CHLORAMPHENICOLThe Lancet, 1987
- Fatal Aplastic Anemia Following Topical Administration of Ophthalmic ChloramphenicolAmerican Journal of Ophthalmology, 1982
- Marrow Aplasia Following Topical Application of Chloramphenicol Eye OintmentArchives of internal medicine (1960), 1980
- CHLORAMPHENICOL EYE-DROPS AND MARROW APLASIAThe Lancet, 1975
- Role of Corticosteroid Regimen On Adrenal Suppression Debated1965
- A FATAL CASE OF APLASTIC ANEMIA FOLLOWING CHLORAMPHENICOL (CHLOROMYCETIN) THERAPYAnnals of Internal Medicine, 1950